Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Regorafenib
Regorafenib
755037-03-7
|
482.815
|
5.185
Regorafenib is a kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma.
BAY73-4506 | CM4308 | Stivarga | regorafenib
Regorafenib is a kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma.
BAY73-4506 | CM4308 | Stivarga | regorafenib
$49/5 mg
(EBC)
1
We provide 0 compound for Regorafenib